AstraZeneca PLC (AZN)
65.85
-0.46
(-0.69%)
USD |
NASDAQ |
Mar 18, 16:00
65.86
+0.01
(+0.02%)
After-Hours: 20:00
AstraZeneca Research and Development Expense (Quarterly): 3.073B for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 3.073B |
September 30, 2023 | 2.584B |
June 30, 2023 | 2.667B |
March 31, 2023 | 2.611B |
December 31, 2022 | 2.625B |
September 30, 2022 | 2.458B |
June 30, 2022 | 2.546B |
March 31, 2022 | 2.133B |
December 31, 2021 | 2.584B |
September 30, 2021 | 3.61B |
June 30, 2021 | 1.829B |
March 31, 2021 | 1.713B |
December 31, 2020 | 1.719B |
September 30, 2020 | 1.495B |
June 30, 2020 | 1.389B |
March 31, 2020 | 1.388B |
December 31, 2019 | 2.091B |
September 30, 2019 | 1.346B |
June 30, 2019 | 1.356B |
March 31, 2019 | 1.266B |
December 31, 2018 | 2.107B |
September 30, 2018 | 1.242B |
June 30, 2018 | 1.362B |
March 31, 2018 | 1.279B |
December 31, 2017 | 1.551B |
Date | Value |
---|---|
September 30, 2017 | 1.404B |
June 30, 2017 | 1.349B |
March 31, 2017 | 1.453B |
December 31, 2016 | 1.543B |
September 30, 2016 | 1.402B |
June 30, 2016 | 1.465B |
March 31, 2016 | 1.48B |
December 31, 2015 | 1.746B |
September 30, 2015 | 1.429B |
June 30, 2015 | 1.466B |
March 31, 2015 | 1.356B |
December 31, 2014 | 1.499B |
September 30, 2014 | 1.552B |
June 30, 2014 | 1.328B |
March 31, 2014 | 1.20B |
December 31, 2013 | 1.429B |
September 30, 2013 | 858.00M |
June 30, 2013 | 1.275B |
March 31, 2013 | 1.259B |
December 31, 2012 | 1.32B |
September 30, 2012 | 1.204B |
June 30, 2012 | 1.189B |
March 31, 2012 | 1.53B |
December 31, 2011 | 1.867B |
September 30, 2011 | 1.296B |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
1.266B
Minimum
Mar 2019
3.61B
Maximum
Sep 2021
2.124B
Average
2.112B
Median
Research and Development Expense (Quarterly) Benchmarks
GSK PLC | 2.542B |
Ionis Pharmaceuticals Inc | 256.56M |
Gracell Biotechnologies Inc (DELISTED) | 12.44M |
Moderna Inc | 1.406B |
RayzeBio inc (DELISTED) | 18.17M |